Decisive events in MS and EAE include activation of myelin‐reactive CD4+ T cells which then differentiate into effector (Th1 and Th17) and regulatory (Treg) at peripheral tissues, and subsequently transmigrate across the BBB.132, 133. This evidence concerns the gene CD4 and myeloid sarcoma.